WHO WE ARE
As a family-held company, we are cognizant of how work shapes who we are and who we aspire to become.
WHO WE ARE Aspiration & Values Leadership Our defining moments Sustainability Global presence
OUR FOCUS
We are a highly specialised company focused on carbohydrate chemistry and a global leader in the development of innovative treatments for patients suffering from iron deficiency and iron deficiency anaemia – a condition which more than 1 billion people live with, making it one of the largest global health challenges of our time.
OUR FOCUS Pharmaceuticals Carbohydrates Animal Health
PROGRAMMES
Discover our current research programme which highlight our commitment to groundbreaking studies and treatments, based on our expertise in iron metabolism.
PROGRAMMES Clinical Trials Petadeferitrin
CAREER
We are a fully integrated pharmaceutical company with many exciting opportunities ahead of us. Do you want to join us?
CAREER Job openings Life at Pharmacosmos
NEWS & MEDIA
We always strive to achieve new results and collaborations that can improve the quality of lives. Stay informed with our latest news and press releases.
NEWS & MEDIA News & Press Events Media
CONTACT US
We welcome all questions or inquiries. Get started by filling out a form or read about the way we are partnering.
CONTACT US Partnering with us Privacy policy

PROGRAMMES

Discover our current research programme, which highlights our commitment to groundbreaking studies and treatments, based on our expertise in iron metabolism.

Growing demand for intravenous iron therapies across existing, new and emerging treatment areas aligns with Pharmacosmos’ long-term commitment to treating iron deficiency. It remains the driving factor behind our research and development, the ongoing direction of our company, and our promise to patients around the world, now and tomorrow. Committed to advancing healthcare through clinical trials, we invite you to explore our ongoing trials that highlight our dedication to research and developing transformative therapies.

Clinical Trials

Discover our clinical programme.

Petadeferitrin

Pharmacosmos is developing petadeferitrin, a novel iron chelator, as a new treatment for patients with transfusional iron overload.